{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:02:20Z","timestamp":1792713740890,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T00:00:00Z","timestamp":1481760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T00:00:00Z","timestamp":1481760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The dopamine transporter (DAT) plays a pivotal role in maintaining optimal dopamine signaling. DAT-overactivity has been linked to various neuropsychiatric disorders yet so far the direct pathological consequences of it has not been fully assessed. We here generated a transgenic rat model that via pronuclear microinjection overexpresses the DAT gene. Our results demonstrate that DAT-overexpression induces multiple neurobiological effects that exceeded the expected alterations in the corticostriatal dopamine system. Furthermore, transgenic rats specifically exhibited behavioral and pharmaco-therapeutic profiles phenotypic of repetitive disorders. Together our findings suggest that the DAT rat model will constitute a valuable tool for further investigations into the pathological influence of DAT overexpression on neural systems relevant to neuropsychiatric disorders.<\/jats:p>","DOI":"10.1038\/srep39145","type":"journal-article","created":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T10:46:29Z","timestamp":1481798789000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Rats overexpressing the dopamine transporter display behavioral and neurobiological abnormalities with relevance to repetitive disorders"],"prefix":"10.1038","volume":"6","author":[{"given":"Ravit","family":"Hadar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henriette","family":"Edemann-Callesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Reinel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Wieske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mareike","family":"Voget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Popova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Sohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosef","family":"Avchalumov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Priller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"van Riesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imke","family":"Puls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,15]]},"reference":[{"key":"BFsrep39145_CR1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0079-6123(08)60655-X","volume":"65","author":"S Matthysse","year":"1986","unstructured":"Matthysse, S. Animal models in psychiatric research. Prog Brain Res 65, 259\u201370 (1986).","journal-title":"Prog Brain Res"},{"key":"BFsrep39145_CR2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1089\/cap.2009.0118","volume":"20","author":"JF Leckman","year":"2010","unstructured":"Leckman, J. F., Bloch, M. H., Smith, M. E., Larabi, D. & Hampson, M. Neurobiological substrates of Tourette\u2019s disorder. J Child Adolesc Psychopharmacol 20, 237\u2013247 (2010).","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"BFsrep39145_CR3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00005792-199101000-00002","volume":"70","author":"HS Singer","year":"1991","unstructured":"Singer, H. S. & Walkup, J. T. Tourette Syndrome and Other Tic Disorders Diagnosis, Pathophysiology, and Treatment. Medicine 70, 15\u201332 (1991).","journal-title":"Medicine"},{"key":"BFsrep39145_CR4","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00004583-199901000-00024","volume":"38","author":"M Ernst","year":"1999","unstructured":"Ernst, M. et al. High presynaptic dopaminergic activity in children with Tourette\u2019s disorder. J. Am. Acad. Child Adolesc. Psychiatry 38, 86\u201394 (1999).","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"BFsrep39145_CR5","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1176\/appi.ajp.159.8.1329","volume":"159","author":"HS Singer","year":"2002","unstructured":"Singer, H. S. et al. Elevated intrasynaptic dopamine release in Tourette\u2019s syndrome measured by PET. Am J Psych. 159, 1329\u201336 (2002).","journal-title":"Am J Psych"},{"key":"BFsrep39145_CR6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pscychresns.2003.06.001","volume":"130","author":"KA Cheon","year":"2004","unstructured":"Cheon, K. A. et al. Dopamine transporter density of the basal ganglia assessed with [123 I] IPT SPECT in drug-naive children with Tourette\u2019s disorder. Psychiatry Res Neuroimaging 130, 85\u201395 (2004).","journal-title":"Psychiatry Res Neuroimaging"},{"key":"BFsrep39145_CR7","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.0001-690X.2004.00214.x","volume":"109","author":"J Serra\u2010Mestres","year":"2004","unstructured":"Serra\u2010Mestres, J. et al. Dopamine transporter binding in Gilles de la Tourette syndrome: a [123I] FP\u2010CIT\/SPECT study. Acta Psychiatric Scand 109, 140\u20136 (2004).","journal-title":"Acta Psychiatric Scand"},{"key":"BFsrep39145_CR8","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.neubiorev.2013.01.016","volume":"37","author":"P Paschou","year":"2013","unstructured":"Paschou, P. The genetic basis of Gilles de la Tourette Syndrome. Neurosci Biobehav Rev 37, 1026\u20131039 (2013).","journal-title":"Neurosci Biobehav Rev"},{"key":"BFsrep39145_CR9","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.euroneuro.2013.05.012","volume":"23","author":"D Denys","year":"2013","unstructured":"Denys, D. et al. Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder. Eur Neuropsychopharmacol 23, 1423\u20131431 (2013).","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFsrep39145_CR10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2165\/00128072-200103050-00004","volume":"3","author":"EH Kossoff","year":"2001","unstructured":"Kossoff, E. H. & Singer, H. S. Tourette syndrome: clinical characteristics and current management strategies. Paediatr Drugs. 3, 355\u201363. (2001).","journal-title":"Paediatr Drugs."},{"key":"BFsrep39145_CR11","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nrneurol.2011.167","volume":"7","author":"KSP McNaught","year":"2011","unstructured":"McNaught, K. S. P. & Mink, J. W. Advances in understanding and treatment of Tourette syndrome. Nat Rev Neurol 7, 667\u2013676 (2011).","journal-title":"Nat Rev Neurol"},{"key":"BFsrep39145_CR12","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1073\/pnas.1419533112","volume":"112","author":"M Xu","year":"2015","unstructured":"Xu, M. et al. Targeted ablation of cholinergic interneurons in the dorsolateral striatum produces behavioral manifestations of Tourette syndrome. PNAS 112, 893\u2013898 (2015).","journal-title":"PNAS"},{"key":"BFsrep39145_CR13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0149-7634(98)00020-7","volume":"23","author":"K Antoniou","year":"1998","unstructured":"Antoniou, K., Kafetzopoulos, E., Papadopoulou-Daifoti, Z., Hyphantis, T. & Marselos, M. D-amphetamine, cocaine and caffeine: a comparative study of acute effects on locomotor activity and behavioural patterns in rats. Neurosci Biobehav Rev 23, 189\u2013196 (1998).","journal-title":"Neurosci Biobehav Rev"},{"key":"BFsrep39145_CR14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.expneurol.2007.10.020","volume":"210","author":"C Winter","year":"2008","unstructured":"Winter, C. et al. High frequency stimulation and temporary inactivation of the subthalamic nucleus reduce quinpirole- induced compulsive checking behavior in rats. Exp Neurol 210, 217\u201328 (2008).","journal-title":"Exp Neurol"},{"key":"BFsrep39145_CR15","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1111\/j.1460-9568.2009.06777.x","volume":"29","author":"A Mundt","year":"2009","unstructured":"Mundt, A. et al. High\u2010frequency stimulation of the nucleus accumbens core and shell reduces quinpirole\u2010induced compulsive checking in rats. Eur J Neurosci 29, 2401\u20132412 (2009).","journal-title":"Eur J Neurosci"},{"key":"BFsrep39145_CR16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bbr.2010.12.036","volume":"219","author":"A Djodari-Irani","year":"2011","unstructured":"Djodari-Irani, A. et al. Activity modulation of the globus pallidus and the nucleus entopeduncularis affects compulsive checking in rats. Behav Brain Res 219, 149\u201358 (2011).","journal-title":"Behav Brain Res"},{"key":"BFsrep39145_CR17","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.beproc.2015.05.004","volume":"118","author":"A Pic-Taylor","year":"2015","unstructured":"Pic-Taylor, A. et al. Behavioural and neurotoxic effects of ayahuasca infusion (Banisteriopsis caapi and Psychotria viridis) in female Wistar rats. Behav Processes 118, 102\u2013110(2015).","journal-title":"Behav Processes"},{"key":"BFsrep39145_CR18","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/sj.npp.1301528","volume":"33","author":"DF Wong","year":"2008","unstructured":"Wong, D. F. et al. Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET. Neuropsychopharmacology 33, 1239\u201351 (2008).","journal-title":"Neuropsychopharmacology"},{"key":"BFsrep39145_CR19","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1212\/01.wnl.0000242733.18534.2c","volume":"67","author":"DL Gilbert","year":"2006","unstructured":"Gilbert, D. L., Christian, B. T., Gelfand, M. J., Shi, B., Mantil, J. & Sallee, F. R. Altered mesolimbocortical and thalamic dopamine in Tourette syndrome. Neurology 67, 1695\u20131697 (2006).","journal-title":"Neurology"},{"key":"BFsrep39145_CR20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/ana.410120408","volume":"12","author":"HS Singer","year":"1982","unstructured":"Singer, H. S., Butler, I. J., Tune, L. E., Seifert, W. E. Jr. & Coyle, J. T. Dopaminergic dsyfunction in Tourette syndrome. Ann Neurol 12, 361\u20136 (1982).","journal-title":"Ann Neurol"},{"key":"BFsrep39145_CR21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ana.410060109","volume":"6","author":"IJ Butler","year":"1979","unstructured":"Butler, I. J., Koslow, S. H., Seifert, W. E. Jr, Caprioli, R. M. & Singer, H. S. Biogenic amine metabolism in Tourette syndrome. Ann Neurol. 6, 37\u20139 (1979).","journal-title":"Ann Neurol."},{"key":"BFsrep39145_CR22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1001\/archpsyc.1978.01770260123015","volume":"35","author":"DJ Cohen","year":"1978","unstructured":"Cohen, D. J., Shaywitz, B. A., Caparulo, B., Young, J. G. & Bowers, M. B. Jr. Chronic, multiple tics of Gilles de la Tourette\u2019s disease. CSF acid monoamine metabolites after probenecid administration. Arch Gen Psychiatry. 35, 245\u201350 (1978).","journal-title":"Arch Gen Psychiatry"},{"key":"BFsrep39145_CR23","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/archneur.1984.04050150060018","volume":"41","author":"AK Shapiro","year":"1984","unstructured":"Shapiro, A. K., Baron, M., Shapiro, E. & Levitt, M. Enzyme activity in Tourette\u2019s syndrome. Arch Neurol 41, 282\u2013285 (1984).","journal-title":"Arch Neurol"},{"key":"BFsrep39145_CR24","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/S0387-7604(03)90011-8","volume":"25","author":"M Segawa","year":"2003","unstructured":"Segawa, M. Neurophysiology of Tourette\u2019s syndrome: pathophysiological considerations. Brain Dev 25, S62\u2013S69 (2003).","journal-title":"Brain Dev"},{"key":"BFsrep39145_CR25","doi-asserted-by":"crossref","first-page":"13307","DOI":"10.1073\/pnas.0502624102","volume":"102","author":"PS Kalanithi","year":"2005","unstructured":"Kalanithi, P. S. et al. Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome. PNAS 102, 13307\u201313312 (2005).","journal-title":"PNAS"},{"key":"BFsrep39145_CR26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/cne.22206","volume":"518","author":"Y Kataoka","year":"2010","unstructured":"Kataoka, Y. et al. Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette syndrome. J Comp Neurol 518, 277\u2013291 (2010).","journal-title":"J Comp Neurol"},{"key":"BFsrep39145_CR27","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/8138","volume":"2","author":"T Ko\u00f3s","year":"1999","unstructured":"Ko\u00f3s, T. & Tepper, J. M. Inhibitory control of neostriatal projection neurons by GABAergic interneurons. Nat Neurosci 2, 467\u2013472 (1999).","journal-title":"Nat Neurosci"},{"key":"BFsrep39145_CR28","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/S0387-7604(03)90012-X","volume":"25","author":"HS Singer","year":"2003","unstructured":"Singer, H. S. & Minzer, K. Neurobiology of Tourette\u2019s syndrome: concepts of neuroanatomic localization and neurochemical abnormalities. Brain Dev 25, S70\u2013S84 (2003).","journal-title":"Brain Dev"},{"key":"BFsrep39145_CR29","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0887-8994(01)00262-4","volume":"25","author":"JW Mink","year":"2001","unstructured":"Mink, J. W. Basal ganglia dysfunction in Tourette\u2019s syndrome: a new hypothesis. Pediatr Neurol 25, 190\u2013198. (2001).","journal-title":"Pediatr Neurol"},{"key":"BFsrep39145_CR30","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.neubiorev.2007.09.005","volume":"32","author":"L Menzies","year":"2008","unstructured":"Menzies, L. et al. Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited. Neurosci Biobehav Rev 32, 525\u2013549 (2008).","journal-title":"Neurosci Biobehav Rev"},{"key":"BFsrep39145_CR31","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1523\/JNEUROSCI.0123-08.2008","volume":"28","author":"N Mallet","year":"2008","unstructured":"Mallet, N. et al. Disrupted dopamine transmission and the emergence of exaggerated beta oscillations in subthalamic nucleus and cerebral cortex. J Neurosci 28, 4795\u20134806 (2008).","journal-title":"J Neurosci"},{"key":"BFsrep39145_CR32","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1177\/0883073812450317","volume":"28","author":"HJ Hong","year":"2013","unstructured":"Hong, H. J. et al. Increased frontomotor oscillations during tic suppression in children with Tourette syndrome. J Child Neurol 28, 615\u2013624 (2013).","journal-title":"J Child Neurol"},{"key":"BFsrep39145_CR33","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/mp.2014.2","volume":"19","author":"WJ Neumann","year":"2014","unstructured":"Neumann, W. J. et al. Different patterns of local field potentials from limbic DBS targets in patients with major depressive and obsessive compulsive disorder. Mol Psych. 19, 1186\u201392 (2014).","journal-title":"Mol Psych"},{"key":"BFsrep39145_CR34","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.nbd.2014.10.016","volume":"74","author":"ST Masoud","year":"2015","unstructured":"Masoud, S. T. et al. \u201cIncreased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits\u201d. Neurobiol dis. 74, 66\u201375 (2015).","journal-title":"Neurobiol dis."},{"key":"BFsrep39145_CR35","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1750-3639.2010.00440.x","volume":"21(3)","author":"G Fazeli","year":"2011","unstructured":"Fazeli, G. et al. \u201cThe role of Dopamine Transporter in Dopamine-Induced DNA Damage\u201d. Brain Pathol 21(3), 237\u2013248 (2011).","journal-title":"Brain Pathol"},{"key":"BFsrep39145_CR36","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1523\/JNEUROSCI.3602-07.2008","volume":"28(2)","author":"L Chen","year":"2008","unstructured":"Chen, L. et al. \u201cUnregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice\u201d. J. Neurosci 28(2), 425\u2013433 (2008).","journal-title":"J. Neurosci"},{"key":"BFsrep39145_CR37","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/archpsyc.64.11.1281","volume":"64","author":"BS Peterson","year":"2007","unstructured":"Peterson, B. S. et al. Morphologic features of the amygdala and hippocampus in children and adults with Tourette syndrome. Arch Gen Psychiatry 64, 1281\u20131291 (2007).","journal-title":"Arch Gen Psychiatry"},{"key":"BFsrep39145_CR38","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s007020050187","volume":"106","author":"M Br\u00fcss","year":"1999","unstructured":"Br\u00fcss, M., Wieland, A. & B\u00f6nisch, H. Molecular cloning and functional expression of the mouse dopamine transporter. J Neural Transm 106, 657\u2013662 (1999).","journal-title":"J Neural Transm"},{"key":"BFsrep39145_CR39","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s11248-005-7218-9","volume":"14","author":"E Popova","year":"2005","unstructured":"Popova, E., Bader, M. & Krivokharchenko, A. Strain differences in superovulatory response, embryo development and efficiency of transgenic rat production. Transgenic Res 14, 729\u2013738 (2005).","journal-title":"Transgenic Res"},{"key":"BFsrep39145_CR40","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0896-6273(90)90308-3","volume":"5","author":"S Forss-Petter","year":"1990","unstructured":"Forss-Petter, S. et al. Transgenic mice expressing \u03b2-galactosidase in mature neurons under neuron-specific enolase promoter control. Neuron 5, 187\u2013197 (1990).","journal-title":"Neuron"},{"key":"BFsrep39145_CR41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0006-8993(94)90767-6","volume":"666","author":"L Mucke","year":"1994","unstructured":"Mucke, L. et al. Synaptotrophic effects of human amyloid \u03b2 protein precursors in the cortex of transgenic mice. Brain Res 666, 151\u2013167 (1994).","journal-title":"Brain Res"},{"key":"BFsrep39145_CR42","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.schres.2015.05.010","volume":"166","author":"R Hadar","year":"2015","unstructured":"Hadar, R. et al. Using a maternal immune stimulation model of schizophrenia to study behavioral and neurobiological alterations over the developmental course. Schiz Res 166, 238\u2013247 (2015).","journal-title":"Schiz Res"},{"key":"BFsrep39145_CR43","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1369-1600.2010.00247.x","volume":"15","author":"DS Carson","year":"2010","unstructured":"Carson, D. S. et al. Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in the hypothalamus. Addict Biol 15, 448\u2013463 (2010).","journal-title":"Addict Biol"},{"key":"BFsrep39145_CR44","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bbr.2015.05.027","volume":"291","author":"M Voget","year":"2015","unstructured":"Voget, M. et al. Altered local field potential activity and serotonergic neurotransmission are further characteristics of the Flinders sensitive line rat model of depression. Behav Brain Res 291, 299\u2013305(2015).","journal-title":"Behav Brain Res"},{"key":"BFsrep39145_CR45","unstructured":"Paxinos, G. & Watson, C., A stereotaxic atlas of the rat brain. New York: Academic (1998)."},{"key":"BFsrep39145_CR46","doi-asserted-by":"crossref","first-page":"6318","DOI":"10.1523\/JNEUROSCI.0620-06.2006","volume":"26","author":"PJ Magill","year":"2006","unstructured":"Magill, P. J. et al. Changes in functional connectivity within the rat striatopallidal axis during global brain activation in vivo. J Neurosci 26, 6318\u20136329 (2006).","journal-title":"J Neurosci"},{"key":"BFsrep39145_CR47","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF00499718","volume":"308","author":"CJ Carter","year":"1979","unstructured":"Carter, C. J. & Pycock, C. J. The effects of 5, 7-dihydroxytryptamine lesions of extrapyramidal and mesolimbic sites on spontaneous motor behaviour, and amphetamine-induced stereotypy. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 308, 51\u201354 (1979).","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"BFsrep39145_CR48","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.brs.2015.02.009","volume":"8","author":"H Edemann-Callesen","year":"2015","unstructured":"Edemann-Callesen, H. et al. Medial Forebrain Bundle Deep Brain Stimulation has Symptom-specific Anti-depressant Effects in Rats and as Opposed to Ventromedial Prefrontal Cortex Stimulation Interacts With the Reward System. Brain Stim 8, 714\u201323 (2015).","journal-title":"Brain Stim"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep39145.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep39145","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep39145.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T03:06:45Z","timestamp":1672888005000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep39145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,15]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,23]]}},"alternative-id":["BFsrep39145"],"URL":"https:\/\/doi.org\/10.1038\/srep39145","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,15]]},"assertion":[{"value":"8 April 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39145"}}